Swiss National Bank West Pharmaceutical Services Inc Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Swiss National Bank holds 216,500 shares of WST stock, worth $72.8 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

216,500

Previous 216,700 0.09%

Holding current value

$72.8 Million

Previous $71.4 Million 8.96%

% of portfolio

0.04%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$277.16 - $333.3 $55,432 - $66,660	-200 Reduced 0.09%	216,500 $65 Million
Q2 2024 Aug 08, 2024	SELL	$314.68 - $395.94 $1.54 Million - $1.94 Million	-4,900 Reduced 2.21%	216,700 $71.4 Million
Q1 2024 May 07, 2024	SELL	$338.27 - $413.0 $3.18 Million - $3.88 Million	-9,400 Reduced 4.07%	221,600 $87.7 Million
Q4 2023 Feb 06, 2024	SELL	$318.29 - $392.21 $2.48 Million - $3.06 Million	-7,800 Reduced 3.27%	231,000 $81.3 Million
Q3 2023 Nov 08, 2023	SELL	$354.9 - $412.41 $10.4 Million - $12.1 Million	-29,400 Reduced 10.96%	238,800 $89.6 Million
Q2 2023 Aug 09, 2023	SELL	$334.63 - $382.47 $8.57 Million - $9.79 Million	-25,600 Reduced 8.71%	268,200 $103 Million
Q1 2023 May 10, 2023	SELL	$232.5 - $346.47 $1.65 Million - $2.46 Million	-7,100 Reduced 2.36%	293,800 $102 Million
Q4 2022 Feb 08, 2023	SELL	$209.34 - $261.61 $4.2 Million - $5.25 Million	-20,075 Reduced 6.25%	300,900 $70.8 Million
Q3 2022 Nov 09, 2022	SELL	$246.08 - $343.65 $295,296 - $412,380	-1,200 Reduced 0.37%	320,975 $79 Million
Q2 2022 Aug 09, 2022	BUY	$280.61 - $420.45 $364,793 - $546,585	1,300 Added 0.41%	322,175 $97.4 Million
Q1 2022 May 09, 2022	BUY	$357.49 - $445.92 $14.2 Million - $17.7 Million	39,700 Added 14.12%	320,875 $132 Million
Q4 2021 Feb 08, 2022	SELL	$402.25 - $471.34 $4.3 Million - $5.04 Million	-10,700 Reduced 3.67%	281,175 $132 Million
Q3 2021 Nov 08, 2021	SELL	$363.01 - $468.47 $3.85 Million - $4.97 Million	-10,600 Reduced 3.5%	291,875 $124 Million
Q2 2021 Aug 06, 2021	SELL	$284.77 - $363.2 $3.57 Million - $4.55 Million	-12,525 Reduced 3.98%	302,475 $109 Million
Q1 2021 May 07, 2021	BUY	$257.29 - $307.53 $9.29 Million - $11.1 Million	36,100 Added 12.94%	315,000 $88.8 Million
Q4 2020 Feb 05, 2021	SELL	$261.16 - $301.66 $1.98 Million - $2.29 Million	-7,600 Reduced 2.65%	278,900 $79 Million
Q3 2020 Nov 09, 2020	SELL	$224.99 - $288.02 $1.28 Million - $1.64 Million	-5,700 Reduced 1.95%	286,500 $78.8 Million
Q2 2020 Aug 05, 2020	BUY	$149.8 - $227.17 $778,960 - $1.18 Million	5,200 Added 1.81%	292,200 $66.4 Million
Q1 2020 May 08, 2020	BUY	$128.96 - $174.76 $7 Million - $9.49 Million	54,300 Added 23.33%	287,000 $43.7 Million
Q4 2019 Feb 06, 2020	BUY	$137.6 - $151.21 $13 Million - $14.3 Million	94,400 Added 68.26%	232,700 $35 Million
Q3 2019 Nov 12, 2019	BUY	$121.41 - $150.02 $36,423 - $45,006	300 Added 0.22%	138,300 $19.6 Million
Q2 2019 Aug 02, 2019	BUY	$111.27 - $125.15 $333,810 - $375,450	3,000 Added 2.22%	138,000 $17.3 Million
Q1 2019 May 10, 2019	BUY	$94.53 - $110.2 $472,650 - $551,000	5,000 Added 3.85%	135,000 $14.9 Million
Q4 2018 Feb 13, 2019	BUY	$93.0 - $123.98 $93,000 - $123,980	1,000 Added 0.78%	130,000 $12.7 Million
Q1 2018 May 04, 2018	BUY	$85.56 - $102.4 $256,680 - $307,200	3,000 Added 2.38%	129,000 $11.4 Million
Q4 2017 Feb 07, 2018	BUY	$91.65 - $101.65 $274,950 - $304,950	3,000 Added 2.44%	126,000 $12.4 Million
Q3 2017 Nov 03, 2017	BUY	$84.54 - $96.75 $10.4 Million - $11.9 Million	123,000	123,000 $11.8 Million

Others Institutions Holding WST

# of Institutions

805

Shares Held

64.9M

Call Options Held

294K

Put Options Held

490K

View Full List

About WEST PHARMACEUTICAL SERVICES INC

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $24.9B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

More about WST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank West Pharmaceutical Services Inc Transaction History